Phase 3 Readout~month

Phase 3 Topline: A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator's Choice of Chemotherapy i

Indication
Ovarian Cancer

Other upcoming events for ZNTL

Phase 2 ReadoutPhase 2 Readout: azenosertib
Phase 2 ReadoutPhase 2 Readout: azenosertib
Phase 2 ReadoutPhase 2 Readout: azenosertib
Phase 2 ReadoutPhase 2 Readout: azenosertib
Phase 3 ReadoutPhase 3 Topline: A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator's Choice of Chemotherapy i

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator's Choice of Chemotherapy i — ZNTL Phase 3 Readout | BioSniper